Page last updated: 2024-11-05

ticlopidine and Click-Murmur Syndrome

ticlopidine has been researched along with Click-Murmur Syndrome in 1 studies

Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.

Research Excerpts

ExcerptRelevanceReference
"1) Myocardial infarction (MI): Aspirin (160-300 mg/day) therapy started immediately after the onset, with or without simultaneous coronary arterial thrombolytic therapy, reduces the mortality rate in vascular diseases, including MI, and prevents reinfarction."3.68[Antiplatelet therapy in cardiac diseases]. ( Aosaki, M; Hosoda, S; Iwade, K; Kimata, S, 1992)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aosaki, M1
Iwade, K1
Kimata, S1
Hosoda, S1

Other Studies

1 other study available for ticlopidine and Click-Murmur Syndrome

ArticleYear
[Antiplatelet therapy in cardiac diseases].
    Nihon rinsho. Japanese journal of clinical medicine, 1992, Volume: 50, Issue:2

    Topics: Angioplasty, Balloon, Coronary; Aspirin; Coronary Artery Bypass; Humans; Mitral Valve Prolapse; Myoc

1992